tirzepatide phase 3 trial 80 weeks weight change Patients on retatrutide for lost an average of 28% of their starting weight. Those who stayed on the drug for 104 weeks lost an average of 30%. This will be game changing for patients with Headline results published this week
Pay in 4 interest-free payments of $5.83 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27




























